Categories Biocon
7 days
30 days
All time
Recent
Popular
Affordable and Accessible research and innovation in an unseen olympics where many Indian companies win ๐ฅ and make the country proud. US enterprises are way ahead in cutting-edge Lab R&D, but they come to ๐ฎ๐ณ for scale-up and affordable manufacturing (CDMO model).
Go ๐ฎ๐ณ Go ๐๐
Go ๐ฎ๐ณ Go ๐๐
Watch the journey of\xa0Insulin Glargine's landmark USFDA approval for first interchangeable #biosimilar for the treatment of diabetes, a testament to #BioconBiologics' scientific excellence & robust quality comparibility data. https://t.co/JSM4LPqYdh
— Biocon (@Bioconlimited) August 1, 2021